Skip to main content

Tesamorelin Visceral Fat Reduction

Meaning

The clinically demonstrated therapeutic effect of Tesamorelin, a synthetic analog of Growth Hormone-Releasing Hormone (GHRH), in selectively reducing excessive visceral adipose tissue (VAT). Visceral fat is metabolically active and strongly correlated with cardiovascular risk and insulin resistance. This targeted reduction is a significant clinical benefit, particularly in specific patient populations with abdominal lipodystrophy.